Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Fowler

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mappingJ S Fowler, G J Wang, J Logan, et al.
Journal of Addictive Diseases|April 29, 1998
Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibitionJ S Fowler, N D Volkow, G J Wang, et al.
Synapse (New York, N.Y.)|May 1, 1992
Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidolD J Schlyer, N D Volkow, J S Fowler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1987
Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucoseE Hiesiger, J S Fowler, A P Wolf, et al.
The Journal of Biological Chemistry|November 27, 2009
TILRR, a novel IL-1RI co-receptor, potentiates MyD88 recruitment to control Ras-dependent amplification of NF-kappaBXiao Zhang, Freya Shephard, Hong B Kim, et al.
The American Journal of Psychiatry|May 1, 1994
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjectsE J Bartlett, J D Brodie, P Simkowitz, et al.
Neurology|October 1, 1993
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327J S Fowler, N D Volkow, J Logan, et al.
Nuclear Medicine and Biology|January 15, 1998
Fluoro-norchloroepibatidine: preclinical assessment of acute toxicityP E Molina, Y S Ding, F I Carroll, et al.
Biological Psychiatry|April 1, 1988
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patientsM Smith, A P Wolf, J D Brodie, et al.
Synapse (New York, N.Y.)|December 1, 1996
Mapping nicotinic acetylcholine receptors with PETY S Ding, S J Gatley, J S Fowler, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mappingJ S Fowler, G J Wang, J Logan, et al.
Journal of Addictive Diseases|April 29, 1998
Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibitionJ S Fowler, N D Volkow, G J Wang, et al.
Synapse (New York, N.Y.)|May 1, 1992
Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidolD J Schlyer, N D Volkow, J S Fowler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1987
Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucoseE Hiesiger, J S Fowler, A P Wolf, et al.
The Journal of Biological Chemistry|November 27, 2009
TILRR, a novel IL-1RI co-receptor, potentiates MyD88 recruitment to control Ras-dependent amplification of NF-kappaBXiao Zhang, Freya Shephard, Hong B Kim, et al.
The American Journal of Psychiatry|May 1, 1994
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjectsE J Bartlett, J D Brodie, P Simkowitz, et al.
Neurology|October 1, 1993
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327J S Fowler, N D Volkow, J Logan, et al.
Nuclear Medicine and Biology|January 15, 1998
Fluoro-norchloroepibatidine: preclinical assessment of acute toxicityP E Molina, Y S Ding, F I Carroll, et al.
Biological Psychiatry|April 1, 1988
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patientsM Smith, A P Wolf, J D Brodie, et al.
Synapse (New York, N.Y.)|December 1, 1996
Mapping nicotinic acetylcholine receptors with PETY S Ding, S J Gatley, J S Fowler, et al.
Pageof 29